ConductScience.org, home

Paper · 28700677

Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.

Saha B and 1 other. PLoS One, 2017. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells. Papers, record 28700677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28700677

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.
PubMed
Journal
PLoS One
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.28
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saha BBratati
2Parks RJRobin Jhttps://orcid.org/0000-0002-4959-2233

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenoviruses, HumanMajor topic
DNA ReplicationMajor topic
Genetic VectorsMajor topic
Cell Line
DNA-Binding Proteins
Gene Products, pol
Hep G2 Cells
Humans
Viral Proteins

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,971,024Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.J Virol1996https://conductscience.org/library/papers/8971024PubMed
215,113,884Activation of adenoviral gene expression by protein IX is not required for efficient virus replication.J Virol2004https://conductscience.org/library/papers/15113884PubMed
319,738,604Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.Mol Ther2010https://conductscience.org/library/papers/19738604PubMed
43,943,131A mechanism for the control of protein synthesis by adenovirus VA RNAI.Cell1986https://conductscience.org/library/papers/3943131PubMed
56,310,869Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein.Virology1983https://conductscience.org/library/papers/6310869PubMed
616,378,998Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.J Virol2006https://conductscience.org/library/papers/16378998PubMed
73,362,670High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus.Nucleic Acids Res1988https://conductscience.org/library/papers/3362670PubMed
87,265,205Structure of the linkage between adenovirus DNA and the 55,000 molecular weight terminal protein.J Mol Biol1981https://conductscience.org/library/papers/7265205PubMed
921,307,207Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.J Virol2011https://conductscience.org/library/papers/21307207PubMed
1015,769,610Functions of the adenovirus E4 proteins and their impact on viral vectors.Front Biosci2005https://conductscience.org/library/papers/15769610PubMed

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42,796,671Target-Based Antiviral Drug Development Against Human Respiratory Viruses.Pathogens2026https://conductscience.org/library/papers/42796671PubMed
42,725,063Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42725063PubMed
42,129,074The Pathology of Viral Infections.Adv Exp Med Biol2026https://conductscience.org/library/papers/42129074PubMed
41,383,016A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses.Mol Ther2026https://conductscience.org/library/papers/41383016PubMed
41,081,511Protein-S-nitrosylation of adenovirus-5 E1A and human papillomavirus 16 E7 limits their ability to inhibit STING activity.J Virol2025https://conductscience.org/library/papers/41081511PubMed
41,078,871Genome-replicating HC-AdV: A novel high-capacity adenoviral vector class featuring enhanced in situ payload expression.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/41078871PubMed
39,037,484Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses.J Microbiol2024https://conductscience.org/library/papers/39037484PubMed
38,689,047In Silico Intensive Analysis for the E4 Gene Evolution of Human Adenovirus Species D.J Microbiol2024https://conductscience.org/library/papers/38689047PubMed
38,523,676Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology.Genes Dis2024https://conductscience.org/library/papers/38523676PubMed
38,338,787Scanning the Horizon for Environmental Applications of Genetically Modified Viruses Reveals Challenges for Their Environmental Risk Assessment.Int J Mol Sci2024https://conductscience.org/library/papers/38338787PubMed

1 to 10 of 25

See all 25 cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28700677

GET https://conductscience.org/api/papers/v1/28700677/references?page=2